Sulfonylurea drug use lead to elevated IL-12 serum levels in type-2 diabetics, induced by peripheral insulin resistance and beta cell dysfunction, as expressed by fasting serum proinsulin levels. The gene discussed is INS; the disease is type 2 diabetes mellitus.